Skip to main content
. 2017 May 7;23(17):3122–3132. doi: 10.3748/wjg.v23.i17.3122

Figure 4.

Figure 4

Disease-free survival of patients in the four groups according to the combined neutrophil-to-lymphocyte ratio with Cancer of the Liver Italian Program score. The median disease-free survival duration in each group was 7.9, 2.3, 2.7, 1.6, and 1.1 mo, respectively (from 2 to 6, P = 0.023). CLIP: Cancer of the Liver Italian Program; NLR: Neutrophil-to-lymphocyte ratio.